These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8337123)

  • 1. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
    Castaigne S; Degos L
    C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
    Wang Z; Sun G; Shen Z; Chen S; Chen Z
    Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
    Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
    Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia].
    Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [All-trans retinoic acid (Tretinoin)].
    Ohno R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):741-6. PubMed ID: 9126315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of hematologic remission in a patient with acute promyelocytic leukemia through the therapeutic use of trans-retinoic acid].
    Skotnicki AB; Stoch A; Sacha T; Nowak WS
    Acta Haematol Pol; 1994; 25(1):69-74. PubMed ID: 8209619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
    Breccia M; Latagliata R; Carmosino I; Cannella L; Diverio D; Guarini A; De Propris MS; Petti MC; Avvisati G; Cimino G; Mandelli F; Lo-Coco F
    Haematologica; 2008 Dec; 93(12):1918-20. PubMed ID: 18945746
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid].
    Ohno R; Naoe T; Fukutani H
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1016-21. PubMed ID: 8390226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid].
    Ohno R
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):189-93. PubMed ID: 8434955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia.
    Parma M; Casaroli I; Pogliani EM
    Haematologica; 1996; 81(4):379-80. PubMed ID: 8870387
    [No Abstract]   [Full Text] [Related]  

  • 14. Genital ulcers after treatment with all-trans-retinoic acid in a child with acute promyelocytic leukemia.
    Unal S; Gümrük F; Cetin M; Hiçsönmez G
    Pediatr Hematol Oncol; 2005; 22(5):357-9. PubMed ID: 16020125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid syndrome in acute promyelocytic leukemia.
    Sentero D; Hosenpud J
    Wis Med J; 1997 Apr; 96(4):35-8. PubMed ID: 9128433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trans-retinoic acid. Treatment by differentiation of acute promyelocytic leukemia].
    Castaigne S
    Soins; 1990; (538-539):24-6. PubMed ID: 2237532
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.
    Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M
    Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia.
    Astudillo L; Loche F; Reynish W; Rigal-Huguet F; Lamant L; Pris J
    Ann Hematol; 2002 Feb; 81(2):111-4. PubMed ID: 11907794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.
    Degos L; Dombret H; Chomienne C; Daniel MT; Micléa JM; Chastang C; Castaigne S; Fenaux P
    Blood; 1995 May; 85(10):2643-53. PubMed ID: 7742522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.